Real-life activity monitoring is feasible and well tolerated by patients. Accelerometer-based measures can quantify disease progression in FRDA over 1 year, providing objective information about patient’s motor activities and supporting the usefulness of these data as complementary outcome measure in interventional trials.
Tuesday, March 19, 2024
Accelerometer-based measures in Friedreich ataxia: a longitudinal study on real-life activity
Accelerometer-based measures in Friedreich ataxia: a longitudinal study on real-life activity. Front. Pharmacol., 19 March 2024, Sec. Neuropharmacology, Volume 15, 2024, doi:10.3389/fphar.2024.1342965
